FEASIBILITY OF USING A FACTORY-CALIBRATED CGM SYSTEM TO DIAGNOSE TYPE 2 DIABETES

被引：0
|
作者：
Frank, S. [1 ]
Hames, K. [2 ]
Jbaily, A. [1 ]
Welsh, J. [2 ]
Stroyeck, C. [1 ]
Price, D. [1 ]
机构：
[1] Dexcom Inc, Data Sci, San Diego, CA USA
[2] Dexcom Inc, Clin Affairs, San Diego, CA USA
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2021年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
O075 / #50
引用
收藏
页码：A48 / A48
页数：1
相关论文
共 50 条
  • [31] Analysis of "Multicenter Evaluation Study Comparing a New Factory-Calibrated Real-Time Continuous Glucose Monitoring System to Existing Flash Glucose Monitoring System"
    Peyser, Thomas
    JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2023, 17 (01): : 214 - 216
  • [32] CGM Attitudes and Adoption among People with Type 2 Diabetes Using One Drop
    Sears, Lindsay
    Imrisek, Steven D.
    Hoy-Rosas, Jamillah R.
    Lavaysse, Lindsey M.
    Lee, Matthew
    Chapman, Matthew R.
    Dachis, Jeff
    DIABETES, 2022, 71
  • [33] Feasibility of CGM use in youth with type 2 diabetes prescribed infrequent glucose monitoring: a randomized controlled trial
    Patel, T.
    Sala, N. Grant
    Glaros, S.
    Chung, S.
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 331 - 332
  • [34] "Clearly": CGM also benefits people with type 2 diabetes
    Kraatz, Katrin
    DIABETES STOFFWECHSEL UND HERZ, 2025, 34 (01):
  • [35] Rapid CGM Uptake among Adults with Type 2 Diabetes
    Mayberry, Lindsay S.
    Hendrickson, Chase
    McCoy, Allison B.
    Elasy, Tom A.
    DIABETES, 2022, 71
  • [36] CGM Use in Adolescents and Young Adults with Type 2 Diabetes
    Fenske, Rachel
    Mann, Elizabeth A.
    DIABETES, 2024, 73
  • [37] USE OF CGM WITH PEOPLE WITH DIABETES TYPE 2 NOT TREATED WITH INSULIN
    Bergenstal, R.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A1 - A2
  • [38] Use of Factory-Calibrated Real-time Continuous Glucose Monitoring Improves Time in Target and HbA1c in a Multiethnic Cohort of Adolescents and Young Adults With Type 1 Diabetes: The MILLENNIALS Study
    Thabit, Hood
    Prabhu, Joshi Navis
    Mubita, Womba
    Fullwood, Catherine
    Azmi, Shazli
    Urwin, Andrea
    Doughty, Ian
    Leelarathna, Lalantha
    DIABETES CARE, 2020, 43 (10) : 2537 - 2543
  • [39] Assessing Patterns of CGM Use and Metrics of Glycemic Control in Type 1 Diabetes and Type 2 Diabetes Patients in the Veterans Healthcare System-Integrating CGM Device Data with EHR Data
    Okuno, Tomoki
    Macwan, Sharon
    Miller, Donald R.
    Norman, Gregory J.
    Reaven, Peter
    Zhou, Jin
    DIABETES, 2024, 73
  • [40] Real world evaluation of people with type 2 diabetes with a 180-day implantable CGM system
    Romarowski, B.
    Tweden, K.
    Mdingi, C. E.
    Kaufman, F. R.
    DIABETOLOGIA, 2024, 67 : S416 - S416
12345